Temporary Codes For Use with Outpatient Prospective Payment System
| Code | Description |
|---|---|
| C1052 | Hemostatic agent, gastrointestinal, topical |
| C1062 | Intravertebral body fracture augmentation with implant (e.g., metal, polymer) |
| C1300 | Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval Terminated December 31, 2014. |
| C1600 | Catheter, transluminal intravascular lesion preparation device, bladed, sheathed (insertable) |
| C1601 | Endoscope, single-use (i.e. disposable), pulmonary, imaging/illumination device (insertable) |
| C1602 | Orthopedic/device/drug matrix/absorbable bone void filler, antimicrobial-eluting (implantable) |
| C1603 | Retrieval device, insertable, laser (used to retrieve intravascular inferior vena cava filter) |
| C1604 | Graft, transmural transvenous arterial bypass (implantable), with all delivery system components |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
| C1714 | Catheter, transluminal atherectomy, directional |
| C1715 | Brachytherapy needle |
| C1716 | Brachytherapy source, non-stranded, gold-198, per source |
| C1717 | Brachytherapy source, non-stranded, high dose rate iridium-192, per source |
| C1719 | Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source |
| C1721 | Cardioverter-defibrillator, dual chamber (implantable) |
| C1722 | Cardioverter-defibrillator, single chamber (implantable) |
| C1724 | Catheter, transluminal atherectomy, rotational |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
| C1726 | Catheter, balloon dilatation, non-vascular |
| C1727 | Catheter, balloon tissue dissector, non-vascular (insertable) |
| C1728 | Catheter, brachytherapy seed administration |
| C1729 | Catheter, drainage |
| C1730 | Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) |
| C1731 | Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes) |
| C1732 | Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping |
| C1733 | Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip |
| C1734 | Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable) |
| C1747 | Endoscope, single-use (i.e. disposable), urinary tract, imaging/illumination device (insertable) |
| C1748 | Endoscope, single-use (i.e. disposable), upper gi, imaging/illumination device (insertable) |
| C1749 | Endoscope, retrograde imaging/illumination colonoscope device (implantable) |
| C1750 | Catheter, hemodialysis/peritoneal, long-term |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
| C1752 | Catheter, hemodialysis/peritoneal, short-term |
| C1753 | Catheter, intravascular ultrasound |
| C1754 | Catheter, intradiscal |
| C1755 | Catheter, intraspinal |
| C1756 | Catheter, pacing, transesophageal |
| C1757 | Catheter, thrombectomy/embolectomy |
| C1758 | Catheter, ureteral |
| C1759 | Catheter, intracardiac echocardiography |
| C1760 | Closure device, vascular (implantable/insertable) |
| C1761 | Catheter, transluminal intravascular lithotripsy, coronary |
| C1762 | Connective tissue, human (includes fascia lata) |
| C1763 | Connective tissue, non-human (includes synthetic) |
| C1764 | Event recorder, cardiac (implantable) |
| C1765 | Adhesion barrier |
| C1766 | Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away |
| C1767 | Generator, neurostimulator (implantable), non-rechargeable |
| C1768 | Graft, vascular |
| C1769 | Guide wire |
| C1770 | Imaging coil, magnetic resonance (insertable) |
| C1771 | Repair device, urinary, incontinence, with sling graft |
| C1772 | Infusion pump, programmable (implantable) |
| C1773 | Retrieval device, insertable (used to retrieve fractured medical devices) |
| C1776 | Joint device (implantable) |
| C1777 | Lead, cardioverter-defibrillator, endocardial single coil (implantable) |
| C1778 | Lead, neurostimulator (implantable) |
| C1779 | Lead, pacemaker, transvenous vdd single pass |
| C1780 | Lens, intraocular (new technology) |
| C1781 | Mesh (implantable) |
| C1782 | Morcellator |
| C1783 | Ocular implant, aqueous drainage assist device |
| C1784 | Ocular device, intraoperative, detached retina |
| C1785 | Pacemaker, dual chamber, rate-responsive (implantable) |
| C1786 | Pacemaker, single chamber, rate-responsive (implantable) |
| C1787 | Patient programmer, neurostimulator |
| C1788 | Port, indwelling (implantable) |
| C1789 | Prosthesis, breast (implantable) |
| C1813 | Prosthesis, penile, inflatable |
| C1814 | Retinal tamponade device, silicone oil |
| C1815 | Prosthesis, urinary sphincter (implantable) |
| C1816 | Receiver and/or transmitter, neurostimulator (implantable) |
| C1817 | Septal defect implant system, intracardiac |
| C1818 | Integrated keratoprosthesis |
| C1819 | Surgical tissue localization and excision device (implantable) |
| C1820 | Generator, neurostimulator (implantable), with rechargeable battery and charging system |
| C1821 | Interspinous process distraction device (implantable) |
| C1822 | Generator, neurostimulator (implantable), high frequency, with rechargeable battery and charging system |
| C1823 | Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads |
| C1824 | Generator, cardiac contractility modulation (implantable) |
| C1825 | Generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation lead(s) |
| C1826 | Generator, neurostimulator (implantable), includes closed feedback loop leads and all implantable components, with rechargeable battery and charging system |
| C1827 | Generator, neurostimulator (implantable), non-rechargeable, with implantable stimulation lead and external paired stimulation controller |
| C1830 | Powered bone marrow biopsy needle |
| C1831 | Interbody cage, anterior, lateral or posterior, personalized (implantable) |
| C1832 | Autograft suspension, including cell processing and application, and all system components |
| C1833 | Monitor, cardiac, including intracardiac lead and all system components (implantable) |
| C1834 | Pressure sensor system, includes all components (e.g., introducer, sensor), intramuscular (implantable), excludes mobile (wireless) software application Terminated March 31, 2023. |
| C1839 | Iris prosthesis |
| C1840 | Lens, intraocular (telescopic) |
| C1841 | Retinal prosthesis, includes all internal and external components Terminated December 31, 2022. |
| C1842 | Retinal prosthesis, includes all internal and external components; add-on to c1841 Terminated December 31, 2022. |
| C1849 | Skin substitute, synthetic, resorbable, per square centimeter Terminated December 31, 2022. |
| C1874 | Stent, coated/covered, with delivery system |
| C1875 | Stent, coated/covered, without delivery system |
| C1876 | Stent, non-coated/non-covered, with delivery system |
| C1877 | Stent, non-coated/non-covered, without delivery system |
| C1878 | Material for vocal cord medialization, synthetic (implantable) |
| C1880 | Vena cava filter |
| C1881 | Dialysis access system (implantable) |
| C1882 | Cardioverter-defibrillator, other than single or dual chamber (implantable) |
| C1883 | Adapter/extension, pacing lead or neurostimulator lead (implantable) |
| C1884 | Embolization protective system |
| C1885 | Catheter, transluminal angioplasty, laser |
| C1886 | Catheter, extravascular tissue ablation, any modality (insertable) |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) |
| C1888 | Catheter, ablation, non-cardiac, endovascular (implantable) |
| C1889 | Implantable/insertable device, not otherwise classified |
| C1890 | No implantable/insertable device used with device-intensive procedures |
| C1891 | Infusion pump, non-programmable, permanent (implantable) |
| C1892 | Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away |
| C1893 | Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
| C1895 | Lead, cardioverter-defibrillator, endocardial dual coil (implantable) |
| C1896 | Lead, cardioverter-defibrillator, other than endocardial single or dual coil (implantable) |
| C1897 | Lead, neurostimulator test kit (implantable) |
| C1898 | Lead, pacemaker, other than transvenous vdd single pass |
| C1899 | Lead, pacemaker/cardioverter-defibrillator combination (implantable) |
| C1900 | Lead, left ventricular coronary venous system |
| C1982 | Catheter, pressure-generating, one-way valve, intermittently occlusive |
| C2596 | Probe, image-guided, robotic, waterjet ablation |
| C2613 | Lung biopsy plug with delivery system |
| C2614 | Probe, percutaneous lumbar discectomy |
| C2615 | Sealant, pulmonary, liquid |
| C2616 | Brachytherapy source, non-stranded, yttrium-90, per source |
| C2617 | Stent, non-coronary, temporary, without delivery system |
| C2618 | Probe/needle, cryoablation |
| C2619 | Pacemaker, dual chamber, non rate-responsive (implantable) |
| C2620 | Pacemaker, single chamber, non rate-responsive (implantable) |
| C2621 | Pacemaker, other than single or dual chamber (implantable) |
| C2622 | Prosthesis, penile, non-inflatable |
| C2623 | Catheter, transluminal angioplasty, drug-coated, non-laser |
| C2624 | Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components |
| C2625 | Stent, non-coronary, temporary, with delivery system |
| C2626 | Infusion pump, non-programmable, temporary (implantable) |
| C2627 | Catheter, suprapubic/cystoscopic |
| C2628 | Catheter, occlusion |
| C2629 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, laser |
| C2630 | Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, cool-tip |
| C2631 | Repair device, urinary, incontinence, without sling graft |
| C2634 | Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source |
| C2635 | Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source |
| C2636 | Brachytherapy linear source, non-stranded, palladium-103, per 1 mm |
| C2637 | Brachytherapy source, non-stranded, ytterbium-169, per source |
| C2638 | Brachytherapy source, stranded, iodine-125, per source |
| C2639 | Brachytherapy source, non-stranded, iodine-125, per source |
| C2640 | Brachytherapy source, stranded, palladium-103, per source |
| C2641 | Brachytherapy source, non-stranded, palladium-103, per source |
| C2642 | Brachytherapy source, stranded, cesium-131, per source |
| C2643 | Brachytherapy source, non-stranded, cesium-131, per source |
| C2644 | Brachytherapy source, cesium-131 chloride solution, per millicurie |
| C2645 | Brachytherapy planar source, palladium-103, per square millimeter |
| C2698 | Brachytherapy source, stranded, not otherwise specified, per source |
| C2699 | Brachytherapy source, non-stranded, not otherwise specified, per source |
| C5271 | Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area |
| C5272 | Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure) |
| C5273 | Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children |
| C5274 | Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure) |
| C5275 | Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area |
| C5276 | Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure) |
| C5277 | Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children |
| C5278 | Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure) |
| C7500 | Debridement, bone including epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if performed, first 20 sq cm or less with manual preparation and insertion of deep (eg, subfacial) drug-delivery device(s) |
| C7501 | Percutaneous breast biopsies using stereotactic guidance, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral and bilateral (for single lesion biopsy, use appropriate code) |
| C7502 | Percutaneous breast biopsies using magnetic resonance guidance, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral or bilateral (for single lesion biopsy, use appropriate code) |
| C7503 | Open biopsy or excision of deep cervical node(s) with intraoperative identification (eg, mapping) of sentinel lymph node(s) including injection of non-radioactive dye when performed |
| C7504 | Percutaneous vertebroplasties (bone biopsies included when performed), first cervicothoracic and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance |
| C7505 | Percutaneous vertebroplasties (bone biopsies included when performed), first lumbosacral and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance |
| C7506 | Arthrodesis, interphalangeal joints, with or without internal fixation |
| C7507 | Percutaneous vertebral augmentations, first thoracic and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (eg, kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance |
| C7508 | Percutaneous vertebral augmentations, first lumbar and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (eg, kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance |
| C7509 | Bronchoscopy, rigid or flexible, diagnostic with cell washing(s) when performed, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed |
| C7510 | Bronchoscopy, rigid or flexible, with bronchial alveolar lavage(s), with computer-assisted image-guided navigation, including fluoroscopic guidance when performed |
| C7511 | Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed |
| C7512 | Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance when performed |
| C7513 | Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty of central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report |
| C7514 | Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with all angioplasty in the central dialysis segment, and transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report |
| C7515 | Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with dialysis circuit permanent endovascular embolization or occlusion of main circuit or any accessory veins, including all required imaging, radiological supervision and interpretation, image documentation and report |
| C7516 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report |
| C7517 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation |
| C7518 | Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging, supervision, interpretation and report |
| C7519 | Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress |
| C7520 | Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) includes intraprocedural injection(s) for bypass graft angiography with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation |
| C7521 | Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography with right heart catheterization with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report |
| C7522 | Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right heart catheterization, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress |
| C7523 | Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report |
| C7524 | Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress |
| C7525 | Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report |
| C7526 | Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress |
| C7527 | Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report |
| C7528 | Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress |
| C7529 | Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress |
| C7530 | Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty and all angioplasty in the central dialysis segment, with transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging, radiological supervision and interpretation, documentation and report |
| C7531 | Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal angioplasty with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation |
| C7532 | Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), initial artery, open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation |
| C7533 | Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy |
| C7534 | Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with atherectomy, includes angioplasty within the same vessel, when performed with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation |
| C7535 | Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal stent placement(s), includes angioplasty within the same vessel, when performed, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation |
| C7537 | Insertion of new or replacement of permanent pacemaker with atrial transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable debribrillator or pacemake pulse generator (eg, for upgrade to dual chamber system) |
| C7538 | Insertion of new or replacement of permanent pacemaker with ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defribrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system) |
| C7539 | Insertion of new or replacement of permanent pacemaker with atrial and ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system) |
| C7540 | Removal of permanent pacemaker pulse generator with replacement of pacemaker pulse generator, dual lead system, with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system) |
| C7541 | Diagnostic endoscopic retrograde cholangiopancreatography (ercp), including collection of specimen(s) by brushing or washing, when performed, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s) |
| C7542 | Endoscopic retrograde cholangiopancreatography (ercp) with biopsy, single or multiple, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s) |
| C7543 | Endoscopic retrograde cholangiopancreatography (ercp) with sphincterotomy/papillotomy, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s) |
| C7544 | Endoscopic retrograde cholangiopancreatography (ercp) with removal of calculi/debris from biliary/pancreatic duct(s), with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s) |
| C7545 | Percutaneous exchange of biliary drainage catheter (eg, external, internal-external, or conversion of internal-external to external only), with removal of calculi/debris from biliary duct(s) and/or gallbladder, including destruction of calculi by any method (eg, mechanical, electrohydraulic, lithotripsy) when performed, including diagnostic cholangiography(ies) when performed, imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation |
| C7546 | Removal and replacement of externally accessible nephroureteral catheter (eg, external/internal stent) requiring fluoroscopic guidance, with ureteral stricture balloon dilation, including imaging guidance and all associated radiological supervision and interpretation |
| C7547 | Convert nephrostomy catheter to nephroureteral catheter, percutaneous via pre-existing nephrostomy tract, with ureteral stricture balloon dialation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation |
| C7548 | Exchange nephrostomy catheter, percutaneous, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation |
| C7549 | Change of ureterostomy tube or externally accessible ureteral stent via ileal conduit with ureteral stricture balloon dilation, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation |
| C7550 | Cystourethroscopy, with biopsy(ies) with adjuctive blue light cystoscopy with fluorescent imaging agent |
| C7551 | Excision of major peripheral nerve neuroma, except sciatic, with implantation of nerve end into bone or muscle |
| C7552 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography and right heart catheterization with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress, initial vessel |
| C7553 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed |
| C7554 | Cystourethroscopy with adjunctive blue light cystoscopy with fluorescent imaging agent |
| C7555 | Thyroidectomy, total or complete with parathyroid autotransplantation |
| C7556 | Bronchoscopy, rigid or flexible, with bronchial alveolar lavage and transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance, when performed |
| C7557 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed and intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention |
| C7558 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed |
| C7560 | Endoscopic retrograde cholangiopancreatography (ercp) with removal of foreign body(s) or stent(s) from biliary/pancreatic duct(s) and endoscopic cannulation of papilla with direct visualization of pancreatic/common bile duct(s) |
| C7900 | Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service |
| C7901 | Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service |
| C7902 | Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, each additional 15 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service (list separately in addition to code for primary service) |
| C7903 | Group psychotherapy service for diagnosis, evaluation, or treatment of a mental health or substance use disorder provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service |
| C8900 | Magnetic resonance angiography with contrast, abdomen |
| C8901 | Magnetic resonance angiography without contrast, abdomen |
| C8902 | Magnetic resonance angiography without contrast followed by with contrast, abdomen |
| C8903 | Magnetic resonance imaging with contrast, breast; unilateral |
| C8904 | Magnetic resonance imaging without contrast, breast; unilateral Terminated December 31, 2018. |
| C8905 | Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral |
| C8906 | Magnetic resonance imaging with contrast, breast; bilateral |
| C8907 | Magnetic resonance imaging without contrast, breast; bilateral Terminated December 31, 2018. |
| C8908 | Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral |
| C8909 | Magnetic resonance angiography with contrast, chest (excluding myocardium) |
| C8910 | Magnetic resonance angiography without contrast, chest (excluding myocardium) |
| C8911 | Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium) |
| C8912 | Magnetic resonance angiography with contrast, lower extremity |
| C8913 | Magnetic resonance angiography without contrast, lower extremity |
| C8914 | Magnetic resonance angiography without contrast followed by with contrast, lower extremity |
| C8918 | Magnetic resonance angiography with contrast, pelvis |
| C8919 | Magnetic resonance angiography without contrast, pelvis |
| C8920 | Magnetic resonance angiography without contrast followed by with contrast, pelvis |
| C8921 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete |
| C8922 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study |
| C8923 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography |
| C8924 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study |
| C8925 | Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report |
| C8926 | Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report |
| C8927 | Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis |
| C8928 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
| C8930 | Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision |
| C8931 | Magnetic resonance angiography with contrast, spinal canal and contents |
| C8932 | Magnetic resonance angiography without contrast, spinal canal and contents |
| C8933 | Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents |
| C8934 | Magnetic resonance angiography with contrast, upper extremity |
| C8935 | Magnetic resonance angiography without contrast, upper extremity |
| C8936 | Magnetic resonance angiography without contrast followed by with contrast, upper extremity |
| C8937 | Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure) |
| C8957 | Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump |
| C9014 | Injection, cerliponase alfa, 1 mg Terminated December 31, 2018. |
| C9015 | Injection, c-1 esterase inhibitor (human), haegarda, 10 units Terminated December 31, 2018. |
| C9016 | Injection, triptorelin extended release, 3.75 mg Terminated December 31, 2018. |
| C9021 | Injection, obinutuzumab, 10 mg Terminated December 31, 2014. |
| C9022 | Injection, elosulfase alfa, 1mg Terminated December 31, 2014. |
| C9023 | Injection, testosterone undecanoate, 1 mg Terminated December 31, 2014. |
| C9024 | Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine Terminated December 31, 2018. |
| C9025 | Injection, ramucirumab, 5 mg Terminated December 31, 2015. |
| C9026 | Injection, vedolizumab, 1 mg Terminated December 31, 2015. |
| C9027 | Injection, pembrolizumab, 1 mg Terminated December 31, 2015. |
| C9028 | Injection, inotuzumab ozogamicin, 0.1 mg Terminated December 31, 2018. |
| C9029 | Injection, guselkumab, 1 mg Terminated December 31, 2018. |
| C9030 | Injection, copanlisib, 1 mg Terminated December 31, 2018. |
| C9031 | Lutetium lu 177, dotatate, therapeutic, 1 mci Terminated December 31, 2018. |
| C9032 | Injection, voretigene neparvovec-rzyl, 1 billion vector genome Terminated December 31, 2018. |
| C9033 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg Terminated December 31, 2018. |
| C9034 | Injection, dexamethasone 9%, intraocular, 1 mcg Terminated December 31, 2018. |
| C9035 | Injection, aripiprazole lauroxil (aristada initio), 1 mg Terminated September 30, 2019. |
| C9036 | Injection, patisiran, 0.1 mg Terminated September 30, 2019. |
| C9037 | Injection, risperidone (perseris), 0.5 mg Terminated September 30, 2019. |
| C9038 | Injection, mogamulizumab-kpkc, 1 mg Terminated September 30, 2019. |
| C9039 | Injection, plazomicin, 5 mg Terminated September 30, 2019. |
| C9040 | Injection, fremanezumab-vfrm, 1mg Terminated September 30, 2019. |
| C9041 | Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg Terminated June 30, 2020. |
| C9042 | Injection, bendamustine hcl (belrapzo), 1 mg Terminated June 30, 2019. |
| C9043 | Injection, levoleucovorin, 1 mg Terminated December 31, 2019. |
| C9044 | Injection, cemiplimab-rwlc, 1 mg Terminated September 30, 2019. |
| C9045 | Injection, moxetumomab pasudotox-tdfk, 0.01 mg Terminated September 30, 2019. |
| C9046 | Cocaine hydrochloride nasal solution (goprelto), 1 mg |
| C9047 | Injection, caplacizumab-yhdp, 1 mg |
| C9048 | Dexamethasone, lacrimal ophthalmic insert, 0.1 mg Terminated September 30, 2019. |
| C9049 | Injection, tagraxofusp-erzs, 10 mcg Terminated September 30, 2019. |
| C9050 | Injection, emapalumab-lzsg, 1 mg Terminated September 30, 2019. |
| C9051 | Injection, omadacycline, 1 mg Terminated September 30, 2019. |
| C9052 | Injection, ravulizumab-cwvz, 10 mg Terminated September 30, 2019. |
| C9053 | Injection, crizanlizumab-tmca, 1 mg Terminated June 30, 2020. |
| C9054 | Injection, lefamulin (xenleta), 1 mg Terminated June 30, 2020. |
| C9055 | Injection, brexanolone, 1mg Terminated September 30, 2020. |
| C9056 | Injection, givosiran, 0.5 mg Terminated June 30, 2020. |
| C9057 | Injection, cetirizine hydrochloride, 1 mg Terminated June 30, 2020. |
| C9058 | Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg Terminated June 30, 2020. |
| C9059 | Injection, meloxicam, 1 mg Terminated September 30, 2020. |
| C9060 | Fluoroestradiol f18, diagnostic, 1 mci Terminated December 31, 2020. |
| C9061 | Injection, teprotumumab-trbw, 10 mg Terminated September 30, 2020. |
| C9062 | Injection, daratumumab 10 mg and hyaluronidase-fihj Terminated December 31, 2020. |
| C9063 | Injection, eptinezumab-jjmr, 1 mg Terminated September 30, 2020. |
| C9064 | Mitomycin pyelocalyceal instillation, 1 mg Terminated December 31, 2020. |
| C9065 | Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg Terminated September 30, 2021. |
| C9066 | Injection, sacituzumab govitecan-hziy, 2.5 mg Terminated December 31, 2020. |
| C9067 | Gallium ga-68, dotatoc, diagnostic, 0.01 mci |
| C9068 | Copper cu-64, dotatate, diagnostic, 1 millicurie Terminated March 31, 2021. |
| C9069 | Injection, belantamab mafodontin-blmf, 0.5 mg Terminated March 31, 2021. |
| C9070 | Injection, tafasitamab-cxix, 2 mg Terminated March 31, 2021. |
| C9071 | Injection, viltolarsen, 10 mg Terminated March 31, 2021. |
| C9072 | Injection, immune globulin (asceniv), 500 mg Terminated March 31, 2021. |
| C9073 | Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Terminated March 31, 2021. |
| C9074 | Injection, lumasiran, 0.5 mg Terminated June 30, 2021. |
| C9075 | Injection, casimersen, 10 mg Terminated September 30, 2021. |
| C9076 | Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Terminated September 30, 2021. |
| C9077 | Injection, cabotegravir and rilpivirine, 2mg/3mg Terminated September 30, 2021. |
| C9078 | Injection, trilaciclib, 1 mg Terminated September 30, 2021. |
| C9079 | Injection, evinacumab-dgnb, 5 mg Terminated September 30, 2021. |
| C9080 | Injection, melphalan flufenamide hydrochloride, 1 mg Terminated September 30, 2021. |
| C9081 | Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Terminated December 31, 2021. |
| C9082 | Injection, dostarlimab-gxly, 100 mg Terminated December 31, 2021. |
| C9083 | Injection, amivantamab-vmjw, 10 mg Terminated December 31, 2021. |
| C9084 | Injection, loncastuximab tesirine-lpyl, 0.1 mg Terminated March 31, 2022. |
| C9085 | Injection, avalglucosidase alfa-ngpt, 4 mg Terminated March 31, 2022. |
| C9086 | Injection, anifrolumab-fnia, 1 mg Terminated March 31, 2022. |
| C9087 | Injection, cyclophosphamide, (auromedics), 10 mg Terminated March 31, 2022. |
| C9088 | Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg |
| C9089 | Bupivacaine, collagen-matrix implant, 1 mg |
| C9090 | Injection, plasminogen, human-tvmh, 1 mg Terminated June 30, 2022. |
| C9091 | Injection, sirolimus protein-bound particles, 1 mg Terminated June 30, 2022. |
| C9092 | Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg Terminated June 30, 2022. |
| C9093 | Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg Terminated June 30, 2022. |
| C9094 | Inj, sutimlimab-jome, 10 mg Terminated September 30, 2022. |
| C9095 | Inj, tebentafusp-tebn, 1 mcg Terminated September 30, 2022. |
| C9096 | Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram Terminated September 30, 2022. |
| C9097 | Inj, faricimab-svoa, 0.1 mg Terminated September 30, 2022. |
| C9098 | Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose Terminated September 30, 2022. |
| C9101 | Injection, oliceridine, 0.1 mg |
| C9113 | Injection, pantoprazole sodium, per vial |
| C9121 | Injection, argatroban, per 5 mg Terminated December 31, 2016. |
| C9122 | Mometasone furoate sinus implant, 10 micrograms (sinuva) Terminated March 31, 2021. |
| C9132 | Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity Terminated June 30, 2021. |
| C9133 | Factor ix (antihemophilic factor, recombinant), rixubis, per i.u. Terminated December 31, 2014. |
| C9134 | Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u. Terminated December 31, 2014. |
| C9135 | Factor ix (antihemophilic factor, recombinant), alprolix, per i.u. Terminated December 31, 2014. |
| C9136 | Injection, factor viii, fc fusion protein, (recombinant), per i.u. Terminated March 31, 2015. |
| C9137 | Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u. Terminated December 31, 2016. |
| C9138 | Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u. Terminated December 31, 2016. |
| C9139 | Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u. Terminated December 31, 2016. |
| C9140 | Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u. Terminated December 31, 2017. |
| C9141 | Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u. Terminated June 30, 2019. |
| C9142 | Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg Terminated December 31, 2022. |
| C9143 | Cocaine hydrochloride nasal solution (numbrino), 1 mg |
| C9144 | Injection, bupivacaine (posimir), 1 mg |
| C9145 | Injection, aprepitant, (aponvie), 1 mg |
| C9146 | Injection, mirvetuximab soravtansine-gynx, 1 mg Terminated June 30, 2023. |
| C9147 | Injection, tremelimumab-actl, 1 mg Terminated June 30, 2023. |
| C9148 | Injection, teclistamab-cqyv, 0.5 mg Terminated June 30, 2023. |
| C9149 | Injection, teplizumab-mzwv, 5 mcg Terminated June 30, 2023. |
| C9150 | Xenon xe-129 hyperpolarized gas, diagnostic, per study dose |
| C9151 | Injection, pegcetacoplan, 1 mg Terminated September 30, 2023. |
| C9152 | Injection, aripiprazole, (abilify asimtufii), 1 mg Terminated December 31, 2023. |
| C9153 | Injection, amisulpride, 1 mg Terminated December 31, 2023. |
| C9154 | Injection, buprenorphine extended-release (brixadi), 1 mg Terminated December 31, 2023. |
| C9155 | Injection, epcoritamab-bysp, 0.16 mg Terminated December 31, 2023. |
| C9156 | Flotufolastat f 18, diagnostic, 1 millicurie Terminated December 31, 2023. |
| C9157 | Injection, tofersen, 1 mg Terminated December 31, 2023. |
| C9158 | Injection, risperidone, (uzedy), 1 mg Terminated December 31, 2023. |
| C9159 | Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity Terminated March 31, 2024. |
| C9160 | Injection, daxibotulinumtoxina-lanm, 1 unit Terminated March 31, 2024. |
| C9161 | Injection, aflibercept hd, 1 mg Terminated March 31, 2024. |
| C9162 | Injection, avacincaptad pegol, 0.1 mg Terminated March 31, 2024. |
| C9163 | Injection, talquetamab-tgvs, 0.25 mg Terminated March 31, 2024. |
| C9164 | Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg) Terminated March 31, 2024. |
| C9165 | Injection, elranatamab-bcmm, 1 mg Terminated March 31, 2024. |
| C9166 | Injection, secukinumab, intravenous, 1 mg |
| C9167 | Injection, apadamtase alfa, 10 units |
| C9168 | Injection, mirikizumab-mrkz, 1 mg |
| C9248 | Injection, clevidipine butyrate, 1 mg |
| C9250 | Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml |
| C9254 | Injection, lacosamide, 1 mg |
| C9257 | Injection, bevacizumab, 0.25 mg |
| C9275 | Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose Terminated December 31, 2018. |
| C9285 | Lidocaine 70 mg/tetracaine 70 mg, per patch |
| C9290 | Injection, bupivacaine liposome, 1 mg |
| C9293 | Injection, glucarpidase, 10 units |
| C9349 | Puraply, and puraply antimicrobial, any type, per square centimeter Terminated December 31, 2016. |
| C9352 | Microporous collagen implantable tube (neuragen nerve guide), per centimeter length |
| C9353 | Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length |
| C9354 | Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter |
| C9355 | Collagen nerve cuff (neuromatrix), per 0.5 centimeter length |
| C9356 | Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter |
| C9358 | Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters |
| C9359 | Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc |
| C9360 | Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters |
| C9361 | Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length |
| C9362 | Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc |
| C9363 | Skin substitute, integra meshed bilayer wound matrix, per square centimeter |
| C9364 | Porcine implant, permacol, per square centimeter |
| C9399 | Unclassified drugs or biologicals |
| C9407 | Iodine i-131 iobenguane, diagnostic, 1 millicurie Terminated December 31, 2019. |
| C9408 | Iodine i-131 iobenguane, therapeutic, 1 millicurie Terminated December 31, 2019. |
| C9441 | Injection, ferric carboxymaltose, 1 mg Terminated June 30, 2014. |
| C9442 | Injection, belinostat, 10 mg Terminated December 31, 2015. |
| C9443 | Injection, dalbavancin, 10 mg Terminated December 31, 2015. |
| C9444 | Injection, oritavancin, 10 mg Terminated December 31, 2015. |
| C9445 | Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units Terminated December 31, 2015. |
| C9446 | Injection, tedizolid phosphate, 1 mg Terminated December 31, 2015. |
| C9447 | Injection, phenylephrine and ketorolac, 4 ml vial Terminated September 30, 2019. |
| C9448 | Netupitant 300 mg and palonosetron 0.5 mg, oral Terminated June 30, 2015. |
| C9449 | Injection, blinatumomab, 1 mcg Terminated December 31, 2015. |
| C9450 | Injection, fluocinolone acetonide intravitreal implant, 0.01 mg Terminated December 31, 2015. |
| C9451 | Injection, peramivir, 1 mg Terminated December 31, 2015. |
| C9452 | Injection, ceftolozane 50 mg and tazobactam 25 mg Terminated December 31, 2015. |
| C9453 | Injection, nivolumab, 1 mg Terminated December 31, 2015. |
| C9454 | Injection, pasireotide long acting, 1 mg Terminated December 31, 2015. |
| C9455 | Injection, siltuximab, 10 mg Terminated December 31, 2015. |
| C9456 | Injection, isavuconazonium sulfate, 1 mg Terminated December 31, 2015. |
| C9457 | Injection, sulfur hexafluoride lipid microsphere, per ml Terminated December 31, 2015. |
| C9458 | Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries Terminated June 30, 2016. |
| C9459 | Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries Terminated June 30, 2016. |
| C9460 | Injection, cangrelor, 1 mg |
| C9461 | Choline c 11, diagnostic, per study dose Terminated December 31, 2016. |
| C9462 | Injection, delafloxacin, 1 mg |
| C9463 | Injection, aprepitant, 1 mg Terminated December 31, 2018. |
| C9464 | Injection, rolapitant, 0.5 mg Terminated December 31, 2018. |
| C9465 | Hyaluronan or derivative, durolane, for intra-articular injection, per dose Terminated December 31, 2018. |
| C9466 | Injection, benralizumab, 1 mg Terminated December 31, 2018. |
| C9467 | Injection, rituximab and hyaluronidase, 10 mg Terminated December 31, 2018. |
| C9468 | Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u. Terminated December 31, 2018. |
| C9469 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg Terminated June 30, 2018. |
| C9470 | Injection, aripiprazole lauroxil, 1 mg Terminated December 31, 2016. |
| C9471 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg Terminated December 31, 2016. |
| C9472 | Injection, talimogene laherparepvec, 1 million plaque forming units (pfu) Terminated December 31, 2016. |
| C9473 | Injection, mepolizumab, 1 mg Terminated December 31, 2016. |
| C9474 | Injection, irinotecan liposome, 1 mg Terminated December 31, 2016. |
| C9475 | Injection, necitumumab, 1 mg Terminated December 31, 2016. |
| C9476 | Injection, daratumumab, 10 mg Terminated December 31, 2016. |
| C9477 | Injection, elotuzumab, 1 mg Terminated December 31, 2016. |
| C9478 | Injection, sebelipase alfa, 1 mg Terminated December 31, 2016. |
| C9479 | Instillation, ciprofloxacin otic suspension, 6 mg Terminated December 31, 2016. |
| C9480 | Injection, trabectedin, 0.1 mg Terminated December 31, 2016. |
| C9481 | Injection, reslizumab, 1 mg Terminated December 31, 2016. |
| C9482 | Injection, sotalol hydrochloride, 1 mg |
| C9483 | Injection, atezolizumab, 10 mg Terminated December 31, 2017. |
| C9484 | Injection, eteplirsen, 10 mg Terminated December 31, 2017. |
| C9485 | Injection, olaratumab, 10 mg Terminated December 31, 2017. |
| C9486 | Injection, granisetron extended release, 0.1 mg Terminated December 31, 2017. |
| C9487 | Ustekinumab, for intravenous injection, 1 mg Terminated June 30, 2017. |
| C9488 | Injection, conivaptan hydrochloride, 1 mg |
| C9489 | Injection, nusinersen, 0.1 mg Terminated December 31, 2017. |
| C9490 | Injection, bezlotoxumab, 10 mg Terminated December 31, 2017. |
| C9491 | Injection, avelumab, 10 mg Terminated December 31, 2017. |
| C9492 | Injection, durvalumab, 10 mg Terminated December 31, 2018. |
| C9493 | Injection, edaravone, 1 mg Terminated December 31, 2018. |
| C9494 | Injection, ocrelizumab, 1 mg Terminated December 31, 2017. |
| C9497 | Loxapine, inhalation powder, 10 mg Terminated December 31, 2018. |
| C9507 | Plasma, high titer covid-19 convalescent, each unit |
| C9600 | Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch |
| C9601 | Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) |
| C9602 | Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch |
| C9603 | Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) |
| C9604 | Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel |
| C9605 | Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure) |
| C9606 | Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel |
| C9607 | Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel |
| C9608 | Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure) |
| C9724 | Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy Terminated December 31, 2015. |
| C9725 | Placement of endorectal intracavitary applicator for high intensity brachytherapy |
| C9726 | Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure |
| C9727 | Insertion of implants into the soft palate; minimum of three implants |
| C9728 | Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple |
| C9733 | Non-ophthalmic fluorescent vascular angiography |
| C9734 | Focused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance |
| C9735 | Anoscopy; with directed submucosal injection(s), any substance Terminated December 31, 2014. |
| C9737 | Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band) Terminated June 30, 2015. |
| C9738 | Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure) |
| C9739 | Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants |
| C9740 | Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants |
| C9741 | Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report Terminated December 31, 2018. |
| C9742 | Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performed Terminated December 31, 2016. |
| C9743 | Injection/implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies) Terminated June 30, 2016. |
| C9744 | Ultrasound, abdominal, with contrast Terminated December 31, 2018. |
| C9745 | Nasal endoscopy, surgical; balloon dilation of eustachian tube Terminated December 31, 2020. |
| C9746 | Transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and/or fluoroscopy, when performed Terminated June 30, 2019. |
| C9747 | Ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidance Terminated December 31, 2020. |
| C9748 | Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy Terminated December 31, 2018. |
| C9749 | Repair of nasal vestibular lateral wall stenosis with implant(s) Terminated December 31, 2020. |
| C9750 | Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode) Terminated December 31, 2018. |
| C9751 | Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (eg, aspiration[s]/biopsy[ies]) and all mediastinal and/or hilar lymph node stations or structures and therapeutic intervention(s) |
| C9752 | Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum Terminated December 31, 2021. |
| C9753 | Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure) Terminated December 31, 2021. |
| C9754 | Creation of arteriovenous fistula, percutaneous; direct, any site, including all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed) Terminated June 30, 2020. |
| C9755 | Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and/or ultrasound, with radiologic supervision and interpretation, when performed Terminated June 30, 2020. |
| C9756 | Intraoperative near-infrared fluorescence lymphatic mapping of lymph node(s) (sentinel or tumor draining) with administration of indocyanine green (icg) (list separately in addition to code for primary procedure) |
| C9757 | Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and excision of herniated intervertebral disc, and repair of annular defect with implantation of bone anchored annular closure device, including annular defect measurement, alignment and sizing assessment, and image guidance; 1 interspace, lumbar |
| C9758 | Blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study |
| C9759 | Transcatheter intraoperative blood vessel microinfusion(s) (e.g., intraluminal, vascular wall and/or perivascular) therapy, any vessel, including radiological supervision and interpretation, when performed |
| C9760 | Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study |
| C9761 | Cystourethroscopy, with ureteroscopy and/or pyeloscopy, with lithotripsy, and ureteral catheterization for steerable vacuum aspiration of the kidney, collecting system, ureter, bladder, and urethra if applicable (must use a steerable ureteral catheter) |
| C9762 | Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with strain imaging |
| C9763 | Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with stress imaging |
| C9764 | Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, includes angioplasty within the same vessel(s), when performed |
| C9765 | Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed |
| C9766 | Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel(s), when performed |
| C9767 | Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel(s), when performed |
| C9768 | Endoscopic ultrasound-guided direct measurement of hepatic portosystemic pressure gradient by any method (list separately in addition to code for primary procedure) |
| C9769 | Cystourethroscopy, with insertion of temporary prostatic implant/stent with fixation/anchor and incisional struts |
| C9770 | Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent Terminated December 31, 2023. |
| C9771 | Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral Terminated December 31, 2023. |
| C9772 | Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies), with intravascular lithotripsy, includes angioplasty within the same vessel (s), when performed |
| C9773 | Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed |
| C9774 | Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel (s), when performed |
| C9775 | Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel (s), when performed |
| C9776 | Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure) |
| C9777 | Esophageal mucosal integrity testing by electrical impedance, transoral, includes esophagoscopy or esophagogastroduodenoscopy |
| C9778 | Colpopexy, vaginal; minimally invasive extra-peritoneal approach (sacrospinous) |
| C9779 | Endoscopic submucosal dissection (esd), including endoscopy or colonoscopy, mucosal closure, when performed |
| C9780 | Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance |
| C9781 | Arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g., balloon), includes debridement (e.g., limited or extensive), subacromial decompression, acromioplasty, and biceps tenodesis when performed |
| C9782 | Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study |
| C9783 | Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catherization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study |
| C9784 | Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components |
| C9785 | Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components |
| C9786 | Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and report |
| C9787 | Gastric electrophysiology mapping with simultaneous patient symptom profiling |
| C9788 | Opto-acoustic imaging, breast (including axilla when performed), unilateral, with image documentation, analysis and report, obtained with ultrasound examination Terminated December 31, 2023. |
| C9789 | Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed |
| C9790 | Histotripsy (ie, non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidance |
| C9791 | Magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast agent, chest, including preparation and administration of agent |
| C9792 | Blinded or nonblinded procedure for symptomatic new york heart association (nyha) class ii, iii, iva heart failure; transcatheter implantation of left atrial to coronary sinus shunt using jugular vein access, including all imaging necessary to intra procedurally map the coronary sinus for optimal shunt placement (e.g., tee or ice ultrasound, fluoroscopy), performed under general anesthesia in an approved investigational device exemption (ide) study) |
| C9793 | 3d predictive model generation for pre-planning of a cardiac procedure, using data from cardiac computed tomographic angiography with report |
| C9794 | Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling) |
| C9795 | Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions |
| C9796 | Repair of enterocutaneous fistula small intestine or colon (excluding anorectal fistula) with plug (e.g., porcine small intestine submucosa [sis]) |
| C9797 | Vascular embolization or occlusion procedure with use of a pressure-generating catheter (e.g., one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction |
| C9800 | Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies Terminated December 31, 2016. |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source Terminated December 31, 2023. |
| C9898 | Radiolabeled product provided during a hospital inpatient stay |
| C9899 | Implanted prosthetic device, payable only for inpatients who do not have inpatient coverage |